 |

James
David Fackenthal, PhD

I received
a B.S in Biology/Geology in 1983 from the University of Rochester.
Afterward I worked for a couple of years as lab tech/non-matriculated
graduate student, studying pattern formation in Drosophila. I continued
Drosophila work as a graduate student with Elizabeth Raff at Indiana
University (Ph.D., 1993), this time focusing on tubulin structure
and microtubule function during spermatogenesis. In 1993 I began
a postdoctoral fellowship at the University of Chicago, applying
my interest in germ cell formation to the study of meiotic regulation
in yeast. As I learned more about cell cycle regulation I became
interested in cancer genetics, so now I work with Funmi Olopade
at the University of Chicago Department of Medicine, where we study
protein structure and splicing regulations of the breast cancer
susceptibility genes BRCA1 and BRCA2, as well as the role of the
PTEN gene in tumor progression.
Inherited susceptibility
to breast and ovarian cancer is primarily caused by germline mutations
in BRCA1 or BRCA2. These tumor suppressor genes encode large proteins
with numerous functions, including DNA repair, transcription, cell
cycle control, and mitotic fidelity. However, the protein structural
requirements for these functions are poorly characterized, and the
transcription and splicing regulation of these genes is not well
understood. We are therefore assembling the complete spectrum and
frequency of BRCA1/2 sequence variants in 1, 000 breast cancer patients
and 1, 000 control subjects from Nigeria. We have found that this
population has the greatest diversity of gene variations identified
thus far, and includes alleles already identified in descendant
populations. This collection of alleles, genotypes, and resulting
haplotypes will be a valuable resource for probing variations in
BRCA1/2 gene expression levels, altered regulation of splice variants,
and protein activities. Initial studies using this collection have
established haplotype structures that are similar to those seen
in other populations, but are extended to include additional markers.
We are also using these markers in conjunction with nonsense-mediated
message decay assays to characterize changes in splice variant frequencies
associated with deleterions mutations. Finally, we are collaborating
with a group at Argonne National Laboratories to identify and characterize
the structural domains of the BRCA1 and BRCA2 proteins, using our
collection of variants to test the physiological consequences of
amino acid substitutions in specific functional domains.
CV
for James David Fackenthal, PhD
Education
B.S. in Biology/Geology, University of Rochester, Department of
Geology, May 1983.
Ph.D. in Molecular, Cellular, and Developmental Biology, Indiana
University, Department of Biology, November 1993. Dissertation Title:
Structural and Functional Analysis of the Testis-Specific Beta-2-Tubulin
in Drosophila melanogaster.
Awards
Predoctoral N.I.H. Training Grant in Genetics, Department of Biology,
Indiana University, January 1988-December 1990.
N.I.H Postdoctoral Fellowship, October 1994-September 1997.
Research
and Related Experience
Laboratory Technician and non-matriculated graduate student, University
of Rochester, Department of Biology, March 1984-August 1986.
Graduate Student
Associate Instructor, Indiana University, Department of Biology,
September 1986-August 1987.
Graduate Student
Research Associate, Indiana University, Department of Biology, September
1987- November 1993.
Postdoctoral
Fellow, University of Chicago, Department of Molecular Genetics
and Cell Biology, November 1993-September 1997.
Postdoctoral
Research Associate, University of Chicago, Department of Molecular
Genetics and Cell Biology, September 1997-April 1999.
Senior Research
Technologist, University of Chicago, Department of Medicine, April
1999-Sept. 2001.
Research Associate
(Instructor), University of Chicago, Department of Medicine, Sept.
2001-August 2002.
Research Associate
(Assistant Professor), University of Chicago, Department of Medicine,
Sept. 2002-present.
Membership
in Professional Societies
American Association for the Advancement of Science
American Association for Cancer Research
American Society for Cell Biology
Genetics Society of America
Awards to
trainees
Basic Science Award to Kevin Long (U of Chicago Medical Student),
Division of Biological Sciences and the Pritzker School of Medicine
Eighth Annual Summer Research Forum, 2002.
Publications
1. Stephenson, E.C., Chao, Y., and Fackenthal, J.D. (1988) Molecular
Analysis of the swallow Gene of Drosophila melanogaster. Genes and
Development 2:1655-1665.
2. Fackenthal, J.D., Turner, F.R., and Raff, E.C. (1993) Tissue-specific
Microtubule Functions in Drosophila Spermatogenesis Require the
Beta-2-tubulin Isotype-Specific Carboxy Terminus. Developmental
Biology 158: 213-227.
3. Fackenthal, J.D., Hutchens, J.A., Turner, F.R., and Raff, E.C.
(1995) Structural Analysis of Mutations in the Drosophila Beta-2-Tubulin
Isoform Reveals Regions in the Beta-tubulin Molecule Required for
General and Tissue-Specific Microtubule Functions. Genetics 139:267-286.
4. Raff, E.C., Fackenthal, J.D., Hutchens, J.A., Hoyle, H.D., and
Turner, F.R. (1997) Microtubule Architecture Specified by a ß-Tubulin
Isoform. Science 275: 70-73.
5. Gao, Q., Tomlinson, G., Das, S., Cummings, S., Sveen, L., Fackenthal,
J., Schumm, P., and Olopade, O. (2000) Prevalence of BRCA1 and BRCA2
mutations Among Clinic-based Populations of African American Women
with Breast Cancer. Human Genetics 107(2):186-191.
6. Gao, Q*.,Adebamowo, C.,* Fackenthal, J.*, Das, S., Sveen, L.,
Falusi, A., Olopade, O. (2000) Protein Truncating BRCA1 and BRCA2
mutations in African women with pre-menopausal breast cancer. Human
Genetics 107(2):192-194.
7. Fackenthal, J, Marsh, D.J., Richardson, A-L., Cummings, S.A.,
Eng, C., Robinson, B., and Olopade, O.I. (2001) Male Breast Cancer
in Cowden Syndrome Patients with Germline PTEN Mutations. J Med
Genet 38: 159-164.
8. Fackenthal, J., Cartegni, L., Krainer, A., and Olopade, O.I.
(2002) BRCA2 T2722R is a deleterious allele that causes exon skipping.
Am J Hum Genet 71:625 *equal contribution
Manuscripts
in Preparation
1. Nanda, R., Fackenthal, JD, Grushko, T., Schumm, P, Pomykala,
H., and Olopade, OI. (in preparation) Clinicopathological features
of BRCA1 and BRCA2-associated tumors.
2. Fackenthal, JD, Sveen, L.,Gao, Q., Adebamowo, C., Das, S., and
Olopade, OI. (in preparation) Complete allelic analysis of BRCA1
and BRCA2 variants in young African breast cancer patients.
3. Fackenthal, JD, Hagos, F., Kretzschmar, E., Lee G, Neuhausen,
S., Das, S., and Olopade, OI. (in preparation) Contribution of PTEN
mutations to male breast cancer.
Invited
Reviews
1. Olopade, O. and Fackenthal, J.D. (2000) Breast Cancer Genetics:
Implications for Clinical Practice. Hematology/Oncology Clinics
of North America, vol. 14 (3). Metcalfe D.D. and Soter, N.A., (eds.)
W.B. Saunders, Philadelphia. 705-725.
2. Fackenthal, J.D. and Olopade, O. (2000) Inherited Susceptibility
to Breast and Ovarian Cancer. Advances in Oncology 16(3):10-18
3. Olopade, O.I. Fackenthal, J.D., Dunston, G., Tainsky, M., Collins,
F., Broome, C. (submitted to Cancer). African American Breast Cancer
Summit Position Paper.
4. Fackenthal,, JD and Olopade, OI (in preparation for Endocrine-Related
Cancer). Cancer genetics of BRCA1 and BRCA2.
Published
Abstracts and Presentations
1. Fackenthal, J.D., Hutchens, J.A., and Raff, E.C. (1990) Analysis
of Various B2t Alleles Reveals Regions of Beta-2-tubulin Required
for Specific Functions. 31st Annual Drosophila Research Conference
(poster).
2. Fackenthal, J.D. and Raff, E.C. (1990) Mutations in the Testis-specific
Beta-2-tubulin Gene. Midwest Drosophila Conference (slide talk).
3. Fackenthal, J.D. and Raff, E.C. (1990) Expression of a Beta-tubulin
Lacking the Diverged Carboxy Terminus in Drosophila melanogaster.
J. Cell Biol. 111:174a. The American Society for Cell Biology 30th
Annual Meeting (poster and published abstract).
4. Fackenthal, J.D. and Raff, E.C. (1991) The Carboxy Terminus of
the Drosophila Beta-2- tubulin is Required for Stability and a Tissue-specific
Function. J. Cell Biol. 115:372a. The American Society for Cell
Biology 31st Annual Meeting (slide talk and published abstract).
5. Fackenthal, J.D. and Raff, E.C. (1991) The Role of the Beta-tubulin
Carboxy Terminus in Spermatogenesis. 32nd Annual Drosophila Research
Conference (poster).
6. Fackenthal, J.D., Turner, F.R., and Raff, E.C. (1993) Tissue-specific
microtubule functions in Drosophila spermatogenesis require the
Beta-2-tubulin isotype-specific carboxy terminus. 34th Annual Drosophila
Research Conference (poster).
7. Raff, E.C., Hoyle, H.D., Dettman, R.W., Fackenthal, J.D., Hutchens,
J.A., and Turner, F.R. (1996) Genetic Analysis of Microtubule Function
in Drosophila. Dev. Biol. 175:376. Society for Developmental Biology
1996 Annual Symposium (presentation with published abstract).
8. Henninger, L., Fackenthal, J.D., and Esposito, R.E. (1996) SPO13
and Control of Meiotic Chromosome Segregation in Saccharomyces cerevisiae.
1996 Yeast Genetics and Molecular Biology Meeting (poster).
9. Fackenthal, J.D. and Esposito, R.E. (1998) CDC28 Regulates the
Levels of Spo13p, a Nuclear Phosphoprotein Required for Two-Division
Meiosis in Saccharomyces cerevisiae. 1998 Yeast Genetics and Molecular
Biology Meeting (slide talk, GSA Travel Award).
10. Olopade, O.I. and Fackenthal, J.D. (2000) Inherited Susceptibility
to Breast Cancer. American Association for Cancer Research, Ninety-First
Annual Meeting (slide talk with published abstract)
11. Fackenthal, J.D., Gao, Q., Sveen, L., Jensen, J., Adebamowo,
C., Das, S., and Olopade, O.I. (2000). Frequency of BRCA1 and BRCA2
mutations in young African breast cancer patients. American Association
for Cancer Research, Ninety-First Annual Meeting (poster with published
abstract)
12. Fackenthal, J.D., Gao, Q., Sveen, L., Jensen, J., Adebamowo,
C., Das, S., and Olopade, O.I. (2000) BRCA1/2 missense mutations
in African and US breast cancer populations. Keystone Symposium:
Advances in Human Breast and Prostate Cancer (poster)
13. Lee G, Fackenthal, JD, S Neuhausen and Olopade, OI. (2001) Contribution
of PTEN mutations to male breast cancer. Midwest Central Society
meeting, 2001 (poster)
14. Fackenthal, J.D., Sveen, L., Kretzschmar, E., Das, S., Adebamowo,
C., and Olopade, OI. (2001) BRCA1/2 Mutations in African Breast
Cancer Patients. Third Annual Workshop on the Function of BRCA1
and BRCA2, Breakthrough Breast Cancer, Cambridge. (poster)
15. Fackenthal, JD, Adebamowo, C., Ogundiran, T., and Olopade, OI.
(2002) Analysis of BRCA2 exon splice enhancer mutations. American
Association for Cancer Research, Ninety-Third Annual Meeting (poster
with published abstract)
16. Fackenthal, J., Lee, G., Hagos, F., Kretzschmar, E., Das, S.,
Neuhausen, S., and Olopade, OI. (2002) PTEN mutations are associated
with male breast cancer. American Association for Cancer Research,
Ninety-Third Annual Meeting (platform talk with published abstract)
17. Byrd, J., Fackenthal, J., Hagos, F., and Olopade, OI. (2002)
Loss of heterozygosity on chromosome 16q21-24 in familial and sporadic
acute myeloid leukemia. American Association for Cancer Research,
Ninety-Third Annual Meeting (poster with published abstract)
|